Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.

<h4>Background</h4>Pfs25 and Pvs25, surface proteins of mosquito stage of the malaria parasites P. falciparum and P. vivax, respectively, are leading candidates for vaccines preventing malaria transmission by mosquitoes. This single blinded, dose escalating, controlled Phase 1 study asse...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yimin Wu, Ruth D Ellis, Donna Shaffer, Erica Fontes, Elissa M Malkin, Siddhartha Mahanty, Michael P Fay, David Narum, Kelly Rausch, Aaron P Miles, Joan Aebig, Andrew Orcutt, Olga Muratova, Guanhong Song, Lynn Lambert, Daming Zhu, Kazutoyo Miura, Carole Long, Allan Saul, Louis H Miller, Anna P Durbin
Format:	article
Language:	EN
Published:	Public Library of Science (PLoS) 2008
Subjects:	Medicine R Science Q
Online Access:	https://doaj.org/article/505909db3b03441eaf9a36aa2240a11a
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.

Similar Items